Download Files:
Products Details
Product Description
– 4′-Raloxifene-β-D-glucopyranoside, a metabolite of Raloxifene, is a benzothiophene glucuronidated at the 4′ postion. 4′-Raloxifene-β-D-glucopyranoside is a selective and orally active estrogen receptor antagonist. 4′-Raloxifene-β-D-glucopyranoside can be used for inhibiting bone loss and resorption, and lowering lipid levels. 4′-Raloxifene-β-D-glucopyranoside, example 5, is extracted from patent US5567820A[1].
Web ID
– HY-135594
Shipping
– Room temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C34H37NO9S
References
– [1]Jeffrey A. Dodge, et al. Glucopyranoside benzothiophenes. Patent US5567820A.
CAS Number
– 334758-19-9
Molecular Weight
– 635.72
SMILES
– O=C(C1=C(C2=CC=C(O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)C=C2)SC4=CC(O)=CC=C41)C5=CC=C(OCCN6CCCCC6)C=C5
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– 10 mM in DMSO
Target
– Estrogen Receptor/ERR
Pathway
– Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
